DrugCards, Tallinn (2026)

07/04/2026

𝗛𝗼𝘄 𝘀𝗮𝗳𝗲 𝗮𝗿𝗲 𝘁𝗵𝗲 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲𝘀 𝗽𝗿𝗲𝘀𝗰𝗿𝗶𝗯𝗲𝗱 𝘁𝗼 𝘄𝗼𝗺𝗲𝗻 𝗼𝗳 𝗿𝗲𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝘃𝗲 𝗮𝗴𝗲?
Recent data reveal that exposure to contraindicated 💊medications is more common than many realise - even before 🤰pregnancy is detected. From chronic disease management to routine prescriptions, the "hidden window" of risk poses real challenges for pharmacovigilance.

✅Our latest article dives into real-world prescribing patterns, highlights pharmacists' role in preventing unintended exposure, and explores strategies to bridge the gap between guidelines and practice.
Every prescription counts - especially when lives could be affected before pregnancy is even known.

👉Read more and join the discussion on improving medication safety in women: https://drug-card.io/blog/medication-safety-in-women-and-the-burden-of-contraindicated-medicines/

31/03/2026

𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗮𝗯𝗹𝗲 𝗔𝗱𝘃𝗲𝗿𝘀𝗲 𝗗𝗿𝘂𝗴 𝗥𝗲𝗮𝗰𝘁𝗶𝗼𝗻𝘀 𝗔𝗿𝗲 𝗦𝘁𝗶𝗹𝗹 𝗛𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 - 𝗕𝘂𝘁 𝗪𝗵𝘆?
Our latest blog on the DrugCard platform dives into a persistent challenge in pharmacovigilance: patients being re-exposed to 💊medications that previously caused adverse reactions.

Even when ADRs are 📑documented, gaps in data sharing, fragmented healthcare systems, and limited patient awareness can still lead to preventable harm.
Sometimes, prevention comes down to one simple question at the point of care:
“𝙃𝙖𝙫𝙚 𝙮𝙤𝙪 𝙚𝙭𝙥𝙚𝙧𝙞𝙚𝙣𝙘𝙚𝙙 𝙖 𝙧𝙚𝙖𝙘𝙩𝙞𝙤𝙣 𝙩𝙤 𝙩𝙝𝙞𝙨 𝙢𝙚𝙙𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙗𝙚𝙛𝙤𝙧𝙚?”
👉Read the full blog and join the conversation on reducing preventable ADRs: https://drug-card.io/blog/preventable-adverse-drug-reactions-and-the-risk-of-forgotten-reactions/

24/03/2026

🎯𝗪𝗵𝗮𝘁 𝗜𝘁 𝗥𝗲𝗮𝗹𝗹𝘆 𝗠𝗲𝗮𝗻𝘀 𝘁𝗼 𝗪𝗼𝗿𝗸 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲: 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗮𝗻 𝗘𝘅𝗽𝗲𝗿𝘁
Pharmacovigilance is not just about data - it’s about the people 👤behind every decision.
Stress. Deadlines. Constant responsibility for patient safety. These are not side notes - they’re reality.
💡In our latest blog, we explore what it really means to work in this space. This interview features insights from Reinhold Schilling on how professionals manage workload, stress, and leadership in high-stakes environments.
Because improving pharmacovigilance isn’t only about systems and automation, it’s also about understanding the people behind them.
🧠If you work in drug safety, this perspective will likely feel very familiar: https://drug-card.io/blog/the-human-side-of-pharmacovigilance-stress-workload-and-leadership-in-high-stakes-environments/

16/03/2026

Thank you, Barcelona 🇪🇸
Our vlog from Spain is now available on YouTube – link in bio.
Check it out!

13/03/2026

🚀 Запрошуємо на онлайн вебінар! 🚀

Тема: Штучний інтелект у фармаконагляді: практичні висновки з семінару ISoP у Базелі

📅 Дата: 25 березня, 12:00

🔍 Теми вебінару:

- Огляд звіту CIOMS Working Group XIV про AI у фармаконагляді

- Принципи впровадження AI в фармаконагляд

- AI-агенти у літературному моніторингу

- Аудити та контроль AI-рішень

Спікер: Артем Горілик, директор з розвитку продуктів, DrugCard

💬 Реєстрація: https://drugcards-26507628.hubspotpagebuilder.eu/webinar-isop?utm_source=facebook&utm_medium=facebook&utm_campaign=facebook&utm_id=facebook

Не пропустіть шанс дізнатися більше про інновації у фармаконагляді з використанням штучного інтелекту!

03/03/2026

𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗮𝗳𝗲𝘁𝘆 𝗦𝘁𝗮𝗿𝘁𝘀 𝗪𝗶𝘁𝗵 𝗪𝗵𝗮𝘁 𝗗𝗼𝗰𝘁𝗼𝗿𝘀 𝗥𝗲𝗽𝗼𝗿𝘁👨🏻‍⚕️
CBD and cannabis oil 🪴are everywhere - people turn to them for pain relief, better sleep, or to calm anxiety. They are often called “natural” and “well-tolerated.” But in reality, what we assume is safe isn’t always harmless.

Fortunately, doctors share their experiences in the 📚medical literature. Published case reports and studies reveal real-world observations, rare reactions, and unexpected interactions that often don’t show up in clinical trials.

👉Read the DrugCard blog to discover why doctors’ insights in the literature are a vital resource for patient safety and smarter pharmacovigilance: https://drug-card.io/blog/cannabis-safety-in-real-life-lessons-from-literature-monitoring/

24/02/2026

💡𝗪𝗵𝘆 𝗦𝗼𝗺𝗲 𝗣𝗿𝗶𝗻𝗰𝗶𝗽𝗹𝗲𝘀 𝗼𝗳 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗪𝗶𝗹𝗹 𝗡𝗲𝘃𝗲𝗿 𝗖𝗵𝗮𝗻𝗴𝗲
AI is revolutionising how we handle case intake. Automation accelerates literature 📚screening. Global databases are more connected than ever.
☝️Yet, despite all this innovation, some things remain constant. Patient safety. Clinical judgment. Documentation. Regulatory compliance. Ethical responsibility. No AI, no automation, no global database can replace the human expertise behind every decision.

We often focus on numbers - case reports, signals, trends - but behind every ICSR is a 👤real person. Every report matters. Every assessment matters. Every decision matters.
💬In our latest blog, we dive into the core principles of pharmacovigilance that will never change - and why they remain the foundation of this fast-evolving field: https://drug-card.io/blog/core-principles-of-pharmacovigilance-that-will-never-change/

18/02/2026

🇪🇸 DrugCard at European Drug Safety & AI 2026
Can’t wait to see you there 🙌🏻

17/02/2026

🎨𝗧𝗵𝗲 𝗔𝗿𝘁 𝗼𝗳 𝗝𝘂𝗱𝗴𝗲𝗺𝗲𝗻𝘁 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲
Pharmacovigilance is not about easy cases.
It is about the report 📑that raises more questions than answers.
The patient has three comorbidities and five concomitant 💊drugs.
The timeline that almost fits. And still, a decision must be made. Clear. Defensible. Regulator-ready.

🎤We spoke with Mircea Ciuca, who regularly handles high-impact and ambiguous safety cases. In our latest blog interview, he shares how he navigates complexity in the real world - from reconstructing incomplete clinical narratives to expressing uncertainty in a way regulators can trust.
💡If you work in PV, this one will feel very familiar: https://drug-card.io/blog/decision-making-in-pv-how-experts-evaluate-uncertain-safety-data/

10/02/2026

🤖𝗔𝗜 𝗶𝗻 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗶𝘀 𝗲𝘃𝗲𝗿𝘆𝘄𝗵𝗲𝗿𝗲, 𝗯𝘂𝘁 𝗰𝗮𝗻 𝗶𝘁 𝗿𝗲𝗮𝗹𝗹𝘆 𝗿𝗲𝗽𝗹𝗮𝗰𝗲 𝗵𝘂𝗺𝗮𝗻 𝗷𝘂𝗱𝗴𝗺𝗲𝗻𝘁?
We rely on automation to process vast volumes of case reports, screen 📚literature, and detect signals faster. Yet some things AI can’t do in pharmacovigilance.

💡Understanding the limits of AI isn’t about resisting technology. It’s about designing smarter workflows where AI supports human expertise, not replaces it.
👉Read the full article to see why human judgment remains central to patient safety and regulatory compliance: https://drug-card.io/blog/what-ai-can-t-do-in-pharmacovigilance-and-why-it-still-matters/

03/02/2026

𝗥𝗲𝗱 𝗙𝗹𝗮𝗴𝘀 🚩𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗛𝗼𝘄 𝘁𝗼 𝗦𝗽𝗼𝘁 𝗧𝗿𝗼𝘂𝗯𝗹𝗲 𝗕𝗲𝗳𝗼𝗿𝗲 𝗜𝘁 𝗦𝗽𝗼𝘁𝘀 𝗬𝗼𝘂
From dating apps to office politics, spotting red flags is in fashion. In pharmacovigilance, it’s far more than a trend - it’s a critical responsibility. Miss a delay in reporting⏰, a spike in adverse events, or hidden safety data, and your patients - and regulators - notice.

🧐Are you confident your team is seeing all the red flags in your safety data?
👉Read the full article on our blog: https://drug-card.io/blog/5-red-flags-in-pharmacovigilance-every-safety-team-must-recognise/

DrugCards

07/04/2026

31/03/2026

24/03/2026

16/03/2026

13/03/2026

03/03/2026

24/02/2026

18/02/2026

17/02/2026

10/02/2026

03/02/2026

Address

Website

Alerts

Contact The Practice

Shortcuts

Share

Category